文献速递主动脉疾病

近肾腹主动脉瘤开放修复、开窗支架与烟囱支架的结局:是否该做随机试验?

Outcomes of Open Repair, Fenestrated Stent Grafting, and Chimney Grafting in Juxtarenal Abdominal Aortic Aneurysm: Is It Time for a Randomized Trial?
PubMed 文献 · Ann Vasc Surg · 2018-11-24

单中心回顾性比较近肾腹主动脉瘤开放修复(32例)、开窗支架(20例)与烟囱支架(23例)的结局。三组围术期死亡率无显著差异,开放组失血量最大,总体生存无差异;开窗与烟囱支架技术成功率高、围术期死亡率低,随访再干预率可接受。

要点

  • 三组围术期死亡率相近,开放组为3.1%(1/32),开窗组0%,烟囱组4.3%(1/23)。
  • 开放组失血量显著最大,其余次要终点组间无显著差异。
  • 开窗与烟囱支架围术期死亡率低,随访再干预率可接受。

核心结论

  • 开放手术是近肾腹主动脉瘤可接受且有效的治疗方式。
  • 开窗与烟囱支架也显示高技术成功率和低围术期死亡率,随访再干预率可接受。

研究设计与样本

  • 开放修复32例,开窗支架(FEVAR)20例,烟囱支架(Ch-EVAR)23例。
  • 主要终点为围术期死亡率,次要终点包括肾功能损害、新发透析、手术细节和术后并发症。

主要发现

  • 三组基线特征无显著差异。
  • 围术期死亡率:开放组3.1%(1/32),开窗组0%,烟囱组4.3%(1/23),组间无显著差异。
  • 平均随访36.7个月(范围1-75个月),除开放组失血量显著最大外,其余次要终点组间无显著差异。
  • 总体生存无显著差异;开窗组1年和4年目标血管支架通畅率均为93.8%,烟囱组均为89.5%。
  • 免于晚期再干预率:开放组96.4%,开窗组77.2%,烟囱组82.3%,组间无显著差异。

临床怎么用

  • 近肾腹主动脉瘤治疗选择需综合评估,开放手术仍是可接受的有效方式。
  • 开窗与烟囱支架可作为围术期风险可接受的替代方案,但需关注随访再干预。

局限性

  • 单中心回顾性研究,样本量较小(开放32例、开窗20例、烟囱23例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The well-established, gold standard treatment for juxtarenal abdominal aortic aneurysms (JAAAs) is open repair (OR). However, endovascular treatment with fenestrated or chimney grafts has been increasingly performed in the past decade. This study compared the outcomes of OR with 2 endovascular methods in JAAA. METHODS: We retrospectively reviewed consecutive patients with JAAA who underwent OR (n = 32), repair with fenestrated stent grafts (fenestrated endovascular aortic aneurysm repair [FEVAR], n = 20), or chimney grafts (Ch-EVAR, n = 23) during the period from January 2011 to December 2016 at a single center. Our primary end point was perioperative mortality. Secondary end points included renal function impairment, new-onset dialysis, procedural details, and postoperative complications. Kaplan-Meier analysis was used to estimate freedom from late reintervention, primary patency of target vessel stent grafts, and overall survival. RESULTS: There were no significant differences between groups in baseline characteristics. Perioperative mortality was similar in all the 3 groups (3.1% (1/32) in the OR group, 0% in the FEVAR group, and 4.3% (1/23) in the Ch-EVAR group. Mean follow-up duration was 36.7 months (range 1-75 months). There were no significant differences between groups regarding any of the secondary end points, except for blood loss (which was significantly greatest in the OR group), and there was no significant difference in overall survival. Estimated target vessel stent patency at 1 and 4 years was 93.8% and 93.8% in the FEVAR group, and 89.5% and 89.5% in the Ch-EVAR group. There was no significant difference between groups in estimated freedom from late reintervention (96.4% in the OR group, 77.2% in the FEVAR group, and 82.3% in the Ch-EVAR group). CONCLUSIONS: Open surgery is an acceptable and effective treatment for JAAA. However, FEVAR and Ch-EVAR also showed high technical success rates and low perioperative mortality, with acceptable reintervention rates during follow-up.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chinsakchai K, Prapassaro T, Salisatkorn W, et al. Outcomes of Open Repair, Fenestrated Stent Grafting, and Chimney Grafting in Juxtarenal Abdominal Aortic Aneurysm: Is It Time for a Randomized Trial? Ann Vasc Surg. 2018. PMID: 30476617. doi:10.1016/j.avsg.2018.08.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。